Massimo Castellani amputee athlete Abu Dhabi is a remarkable story of resilience and hope. After losing his right leg to a rare infection caused by a Rocky Mountain Tick bite during a trip in late 2023.
Massimo Castellani amputee athlete Abu Dhabi is a remarkable story of resilience and hope. After losing his right leg to a rare infection caused by a Rocky Mountain Tick bite during a trip in late 2023.

Massimo Castellani amputee athlete Abu Dhabi is a remarkable story of resilience and hope. After losing his right leg to a rare infection caused by a Rocky Mountain Tick bite during a trip in late 2023, Italian athlete Massimo thought his athletic career—and life—were over. His leg swollen with unbearable pain and infection spreading to his lungs, doctors made a life-saving decision to amputate above the knee.
Plunged into depression and isolation, Massimo was reminded by friends of his fighting spirit. He embraced adaptive sports like archery, air rifle, sitting volleyball, and fencing, reigniting his passion and purpose. His skill with the air rifle has set him on a new goal: to represent Italy at the Paralympic Games.
Massimo’s journey took a transformative turn when he received osseointegration surgery under Abu Dhabi’s humanitarian ‘10 Journeys Initiative,’ led by Dr Shamsheer Vayalil and performed by world-renowned orthopaedic surgeon Prof. Dr. Munjed Al Muderis at Burjeel Medical City. The innovative procedure anchors a titanium implant directly to the bone, offering superior comfort and mobility compared to traditional socket prosthetics.
Now pain-free and walking confidently, Massimo calls this surgery “the beginning of a new life.” Training daily in Abu Dhabi, he embodies hope and strength, aiming to inspire those facing adversity. “If I make it to the Paralympics, it will not just be for me, but for everyone who thinks their story is over,” he says. “Because it is never over.”
Keep in touch with our news & offers
Thank you for subscribing to the newsletter.
Oops. Something went wrong. Please try again later.
Thank you for subscribing to the newsletter.
Oops. Something went wrong. Please try again later.